BankPlus Trust Department’s Moderna MRNA Stock Holding History

BankPlus Trust Department’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$210	Hold	3	–	–	﹤0.01%	468
2026 Q1	$152	Hold	3	–	–	﹤0.01%	463
2025 Q4	$88	Hold	3	–	–	﹤0.01%	457
2025 Q3	$77	Hold	3	–	–	﹤0.01%	450
2025 Q2	$83	Hold	3	–	–	﹤0.01%	440
2025 Q1	$85	Buy	+3	New	+$106	﹤0.01%	473

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

BankPlus Trust Department's MRNA Position: Q2 2026 in Review

BankPlus Trust Department held its Moderna (MRNA) position steady in Q2 2026 at 3 shares worth $210. The position accounts for ﹤0.01% of the portfolio, ranked #468.

BankPlus Trust Department first reported a position in MRNA in Q1 2025 and has held it in 6 quarters since. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

BankPlus Trust Department held 3 shares of Moderna worth $210 as of Q2 2026.
BankPlus Trust Department left its Moderna share count unchanged in Q2 2026.
Moderna made up ﹤0.01% of BankPlus Trust Department's portfolio in Q2 2026, its #468 holding.
BankPlus Trust Department first reported a position in Moderna in Q1 2025 and has held it in 6 quarters since.
784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on BankPlus Trust Department's 13F filing for Q2 2026, filed 28 Jul 2026.